XML 81 R70.htm IDEA: XBRL DOCUMENT v3.25.3
Investment in Loans (Schedule of Commercial Mortgage Loans) (Details) (Details)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2025
USD ($)
loan
Dec. 31, 2024
USD ($)
loan
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Unpaid Principal Balance $ 14,926,381 $ 13,657,446
Unamortized Premium (Discount) (483,221) (389,777)
Loans, at fair value(1)(2) [1],[2] $ 15,531,299 $ 13,999,572
Weighted Average    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Weighted Average Coupon 4.64% 4.77%
Weighted Average Yield 9.07% 6.58%
Weighted average life 5 years 3 months 3 days 5 years 11 months 26 days
Commercial mortgage loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Unpaid Principal Balance $ 546,466 $ 370,658
Unamortized Premium (Discount) (866) (8,341)
Investments, at fair value, Cost 545,600 362,317
Gains 145 0
Losses (71) (11,802)
Loans, at fair value(1)(2) 545,674 $ 350,515
Number of mortgage loans in process of foreclosure   1
Mortgage Loans In Process Of Foreclosure, Unpaid Principal Balance   $ 15,500
Commercial mortgage loans | Non-performing    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Unpaid Principal Balance 61,500 56,500
Loans, at fair value(1)(2) $ 60,700 $ 37,600
Number of loans | loan 8 4
Commercial mortgage loans | Weighted Average    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Weighted Average Coupon 10.05% 10.55%
Weighted Average Yield 9.92% 10.59%
Weighted average life 1 year 1 month 13 days 1 year 2 months 19 days
Non-accrual status [Member] | Commercial mortgage loans | Non-performing    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, at fair value(1)(2) $ 60,700 $ 37,600
[1] Ellington Financial Inc.'s Condensed Consolidated Balance Sheets include assets and liabilities of variable interest entities it has consolidated. See Note 12 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.
[2] Includes assets pledged as collateral to counterparties. See Note 14 for additional details on the Company's borrowings and related collateral.